Urine 5MedC, a Marker of DNA Methylation, in the Progression of Chronic Kidney Disease

BACKGROUND: Alterations in DNA methylation may be involved in disease progression in patients with chronic kidney disease (CKD). Recent studies have suggested that 5-methyl-2′-deoxycytidine (5MedC) may be a marker of hypermethylation of DNA. Currently, there is no information available regarding the...

Descripción completa

Detalles Bibliográficos
Autores principales: Onishi, Akifumi, Sugiyama, Hitoshi, Kitagawa, Masashi, Yamanari, Toshio, Tanaka, Keiko, Ogawa-Akiyama, Ayu, Kano, Yuzuki, Mise, Koki, Tanabe, Katsuyuki, Morinaga, Hiroshi, Kinomura, Masaru, Uchida, Haruhito A., Wada, Jun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6636573/
https://www.ncbi.nlm.nih.gov/pubmed/31354889
http://dx.doi.org/10.1155/2019/5432453

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6636573/
https://www.ncbi.nlm.nih.gov/pubmed/31354889
http://dx.doi.org/10.1155/2019/5432453

Ejemplares similares